etc-1922159
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2015 (NCT02521844)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
PORCN inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
Cn1c(=O)c2c(ncn2CC(=O)Nc2ccc(-c3ccccc3)nn2)n(C)c1=O- Mol. weight
- 391.39 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3633802 ↗
Also known as
- etc-1922159
- etc-1922159
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06513624 | Phase 1 | Nov 30, 2024 | A*Star, National University of Singapore |
| NCT02521844 | Phase 1 | Oct 1, 2015 | A*Star, PPD |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| A*Star | Government | 2 | 1 | 1 | 2015 |
| National University of Singapore | Academic/Hospital | 1 | 1 | 1 | 2024 |
| PPD | For profit | 1 | 0 | 1 | 2015 |
3 organizations
Page 1 / 1